Hormone Therapy, Breast Cancer Risk and the Collaborative Group on Hormonal Factors in Breast Cancer Article

摘要

In August 2019, the safety of menopausal hormone therapy(MHT) returned to the scene again. Oncemore, its associationwith breast cancer risk came up, this time in an articlepublished in the prestigious The Lancet (online in Augustand printed in September/2019). The subject is not new, andauthors of the article are not newcomers either. By representingthe Collaborative Group on Hormonal Factors inBreast Cancer, they brought a reanalysis of data from studieson the subject published so far.